This 2018 in vitro study evaluated the effects of methylsulfonylmethane (MSM) on prostate cancer cell lines LNCaP, PC3, and DU-145. MSM treatment led to decreased cell viability and invasiveness by inducing apoptosis and causing cell cycle arrest at the G0/G1 phase. At a concentration of 200 mM, MSM significantly reduced
